Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Paul C Moorehead"'
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-6 (2019)
Abstract Background With significant improvements in the survival rates for most childhood cancers, there is increased pressure to determine how follow-up or aftercare for survivors is best structured. Main body Previous work in this area has not bee
Externí odkaz:
https://doaj.org/article/62ad671a1d134507adcaf3fa872e9114
Autor:
Modeline N. Longjohn, Jo-Anna B. J. Hudson, Lourdes Peña-Castillo, Robert P. J. Cormier, Brandon Hannay, Simi Chacko, Stephen M. Lewis, Paul C. Moorehead, Sherri L. Christian
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Pediatric B-acute lymphoblastic leukemia (B-ALL) is a disease of abnormally growing B lymphoblasts. Here we hypothesized that extracellular vesicles (EVs), which are nanosized particles released by all cells (including cancer cells), could be used to
Externí odkaz:
https://doaj.org/article/0206816f2bc04a5a92870c93598d1fef
Autor:
Maria T. Georgescu, Paul C. Moorehead, Alice S. van Velzen, Kate Nesbitt, Birgit M. Reipert, Katharina N. Steinitz, Maria Schuster, Christine Hough, David Lillicrap
Publikováno v:
Haematologica, Vol 103, Iss 8 (2018)
The development of inhibitory antibodies to factor VIII is the most serious complication of replacement therapy in hemophilia A. Activation of the innate immune system during exposure to this protein contributes to inhibitor development. However, avo
Externí odkaz:
https://doaj.org/article/795636410fc144f29549cf2ed3ff147e
Autor:
Maria T. Georgescu, Paul C. Moorehead, Tongyao Liu, Jennifer Dumont, David W. Scott, Christine Hough, David Lillicrap
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The development of neutralizing antibodies (inhibitors) against factor VIII (FVIII) is a major complication of hemophilia A treatment. The sole clinical therapy to restore FVIII tolerance in patients with inhibitors remains immune tolerance induction
Externí odkaz:
https://doaj.org/article/a2ee070406e647a2aa15fff3c1819720